Taken together, overexpression of antiapoptotic proteins through the mitochondrial pathway (for example, Bcl-2) may represent a specific, effective molecular treatment option in degenerative disc disease. This evidence concerns the gene BCL2 and intervertebral disk degenerative disorder.